• Partnerships
• Publications
• Multimedia
• Worksheets
• Guides
• Toolbox/Catalog
• Databases
• Services

What is an FDA reporting meeting amendment and why is it important in drug development?

FDA reporting meeting amendments are conducted after the completion of the IND application but prior to the official ruling on an NDA. They provide the sponsor with the opportunity to discuss their application with regulatory officials and make the necessary updates. Members of the community, including patients, advocates, and researchers, are also allowed to offer their perspective on an investigational compound to regulatory officials.

Testimonials: How we did it

Relevant publications

Related Tools